Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
Aging Frailty with Influenza Vaccine Trial announced by Longeveron

Aging Frailty with Influenza Vaccine Trial announced by Longeveron

by admin | Jan 21, 2018 | News & Opinions, Science

America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...

Recent Posts

  • UC Berkeley researchers discover ancestor of gene-editing tool CRISPR
  • Could Inhaled Cell Therapy Change the Course of COPD?
  • Healthspan Action Coalition and Leading Italian Organizations Announce Global Collaboration
  • Launching “Healthspan for All” at the Translational Longevity Summit
  • 3D-printed spheroids enable dual bone and vascular tissue development
Tweets about @WSCSummit